glp-1 controversy Hims & Hers Super Bowl ad for new weight loss drugs faces backlash from health experts 🔸 Should GLP-1 RAs be

A new study published in The Lancet Regional Health found that use of GLP-1 receptor agonists in the context of weight-loss treatment is associated with declines in lean (muscle) mass unless accompanied by targeted strength training interventions

EC population in the crypt expresses tachykinin (Tac1) and tryptophan hydroxylase-1 (Tph1) but the EC population in the villus expresses Sct and Tph1 [25] (Fig

Depending on the plan selected with your provider, you'll receive either compounded semaglutide or, if approved and chosen, a name-brand version like Ozempic or Wegovy

Additionally, some peptide users may experience increased fluid retention, leading to a puffy appearance and aggravating conditions like hypertension

MyNetDiary does not provide medical advice